Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced
Inv. presentation
Quarterly results
Appointed director
CC transcript
Auditor change
Director departure

JUNIPER PHARMACEUTICALS INC (JNP) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/27/2018 GN Gainey McKenna & Egleston Announces that Class Action Lawsuit Has Been Filed Against Juniper Pharmaceuticals, Inc. (JNP) And Its Directors
07/11/2018 GN MERGER ALERT -- WEB, EDR, JNP: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
07/11/2018 GN MERGER ALERT -- WEB, EDR, JNP: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
07/06/2018 GN INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Juniper Pharmaceuticals, Inc. to Catalent Inc. is Fair to Shareholders
07/06/2018 GN Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Juniper Pharmaceuticals, Inc. (JNP) on Behalf of Stockholders and Encourages Investors to Contact the Firm
05/30/2017 GN George O. Elston Named Chief Executive Officer of 2X Oncology
01/20/2012 PRN FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length
06/27/2011 PRN Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA
06/24/2011 BW Columbia Laboratories Added to Russell 3000 Index
05/16/2011 BW Columbia Laboratories Added to NASDAQ Biotechnology Index
05/10/2011 BW Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
05/05/2011 BW Columbia Laboratories Reports First Quarter 2011 Financial Results
04/28/2011 BW Columbia Laboratories to Discuss First Quarter 2011 Financial Results on May 5, 2011, Conference Call
04/26/2011 PRN Columbia Laboratories Submits NDA for PROCHIEVE® Vaginal Progesterone Gel
04/20/2011 BW Actient Pharmaceuticals LLC Acquires U.S. Rights to STRIANT from Columbia Laboratories
04/06/2011 PRN Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
03/30/2011 BW Columbia Laboratories' Provides Update on PREGNANT Study Publication
03/10/2011 BW Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results
02/24/2011 PRN Columbia Laboratories to Discuss Fourth Quarter and Year End 2010 Financial Results on March 10, 2011, Conference Call
11/04/2010 BW Columbia Laboratories Reports Third Quarter 2010 Financial Results
10/21/2010 BW Columbia Laboratories to Discuss Third Quarter 2010 Financial Results on November 4 Conference Call
10/18/2010 BW Columbia Laboratories to Present at the NewsMakers in the Biotech Industry Conference on October 22, 2010

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy